Drug recall · June 26, 2024
Eptifibatide injection 20mg/10mL recall
Why: Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10
- Lots / codes
Lot #: 3EF22003, Exp 6/30/2025
- Quantity
- 15,500 single dose vials
- Company
- Eugia US LLC, East Windsor, NJ
- Distribution
- USA nationwide.
- Initiated
- May 22, 2024 · Voluntary: Firm initiated
- Classified
- June 14, 2024
- Reported
- June 26, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Eptifibatide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.